Opening Address & Keynote Presentation:
18 Sep 2025
Autologous Therapies in Solid Tumors and Beyond
Allogeneic Access: Engineering the Future of Cell Therapy
Cell Therapy Manufacturing: Automation, Assays & the Allo-Auto Divide
Next Gen Vector Engineering & Delivery
Gene Therapy CMC & Process Development
Commercializing Gene Therapy in 2025